Biospace.com

Antibody Drug Conjugate Market Antibody drug conjugates (ADCs), also known as anti-cancer drugs are promising and effective modalities for cancer therapies. The Antibody drug conjugates ADCs are prepared by combining two principles i.e. monoclonal antibody...

Immunomedics, Inc. (NASDAQ:IMMU) ­was a big winner towards the end of last week, as the company put out news that it had scored a deal with fellow biotech entity Seattle Genetics, Inc. (NASDAQ:SGEN) related to one of its lead development assets. The...

Alex Lash We’ve grouped our items according to topic this week. First come the financings, led by the relocated Laguna Pharma in San Diego. Then comes the clinical and regulatory news, which is topped by the long-awaited results of a government-sponsored...

The West Coast biotech put up $250 million to license Immunomedics therapy, with milestone payments pushing total deal value potentially as high as $2 billion. 

Summary Tax experts say new rules will not derail Pfizer-Allergan deal. Agenus has an extensive pipeline and partnerships. Depomed falls sharply as Horizon withdraws offer. (Announcing November Discounts. Only for the month of November, the first...